Portfolio
New Drug R&D
ANYA BIOPHARM INC. utilizing the MIRA/JE® patent platform to overcome challenges in oral peptide drug delivery.
New Drug R&D
Onward therapeutics is a development stage oncology company, focusing on bi-specific antibody and allogenic NK-cell therapy.
New Drug R&D
Immunwork focuses on the R&D of a class of new drugs, which are created based on our proprietary “T-E pharmaceuticals” technology platform.
New Drug R&D
AiVivia's JEL™ delivery method directly targets local disorders with minimal systemic exposure, a basis for a favorable benefit-risk profile.
New Drug R&D
Core Business
Lumosa is a clinical-stage pharmaceutical company dedicated to the development of novel solutions for neurological and oncological diseases.
New Drug R&D
Core Business
Bao Pharmaceuticals focuses on the development and commercialization of recombinant protein drugs and antibody drugs.
New Drug R&D
Jacobio is a biopharmaceutical company that develops innovative drugs. It targets undruggable proteins with allosteric mechanisms and molecules.